SageView Advisory Group LLC acquired a new position in shares of Humana Inc. (NYSE:HUM - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 1,364 shares of the insurance provider's stock, valued at approximately $346,000.
Other institutional investors also recently made changes to their positions in the company. MML Investors Services LLC boosted its holdings in Humana by 15.6% in the third quarter. MML Investors Services LLC now owns 4,737 shares of the insurance provider's stock worth $1,500,000 after purchasing an additional 638 shares during the period. Virtu Financial LLC bought a new stake in shares of Humana during the 3rd quarter valued at about $631,000. Wilmington Savings Fund Society FSB acquired a new stake in Humana during the third quarter worth about $948,000. Tidal Investments LLC boosted its stake in Humana by 38.4% in the third quarter. Tidal Investments LLC now owns 24,357 shares of the insurance provider's stock valued at $7,715,000 after acquiring an additional 6,755 shares during the period. Finally, Synovus Financial Corp raised its position in shares of Humana by 4.1% during the 3rd quarter. Synovus Financial Corp now owns 2,254 shares of the insurance provider's stock worth $714,000 after purchasing an additional 89 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.
Humana Stock Performance
Shares of NYSE:HUM traded down $21.20 during trading on Friday, hitting $264.41. 3,670,273 shares of the stock were exchanged, compared to its average volume of 1,757,258. The company has a market capitalization of $31.91 billion, a price-to-earnings ratio of 26.57, a price-to-earnings-growth ratio of 2.05 and a beta of 0.62. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46. The company's fifty day simple moving average is $265.90 and its 200-day simple moving average is $269.86.
Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping analysts' consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Sell-side analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.
Humana Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.34%. Humana's dividend payout ratio is currently 35.58%.
Analyst Ratings Changes
A number of research firms have issued reports on HUM. Piper Sandler boosted their target price on shares of Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a research note on Wednesday, January 15th. Guggenheim began coverage on Humana in a research report on Wednesday, April 9th. They issued a "buy" rating and a $326.00 target price for the company. Mizuho lifted their price target on Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. Robert W. Baird raised their target price on Humana from $270.00 to $300.00 and gave the company a "neutral" rating in a research note on Tuesday. Finally, Royal Bank of Canada reiterated an "outperform" rating and issued a $283.00 price target on shares of Humana in a research report on Wednesday, February 12th. Seventeen investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $284.90.
Read Our Latest Stock Report on HUM
Humana Profile
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Further Reading
Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
